Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 2
1991 1
1992 1
1996 1
1997 2
2001 4
2002 5
2003 2
2004 5
2005 2
2006 4
2007 6
2008 5
2009 9
2010 5
2011 4
2012 12
2013 6
2014 3
2015 6
2016 5
2017 3
2018 2
2021 2
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
Aschoff R, Möller S, Haase R, Kuske M. Aschoff R, et al. J Drugs Dermatol. 2021 Mar 1;20(3):295-301. doi: 10.36849/JDD.2021.5641. J Drugs Dermatol. 2021. PMID: 33683070 Clinical Trial.
This evaluator-blinded pilot study compared the efficacy and tolerability of two marketed topical combination acne gels, clindamycin 1%-tretinoin 0.025% (CT) and benzoyl peroxide 2.5%-adapalene 0.1% (BA) in 20 patients with mild to moderate acne vulgaris. ...
This evaluator-blinded pilot study compared the efficacy and tolerability of two marketed topical combination acne gels, clindamycin …
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Stein Gold L, et al. Am J Clin Dermatol. 2022 Jan;23(1):93-104. doi: 10.1007/s40257-021-00650-3. Epub 2021 Oct 21. Am J Clin Dermatol. 2022. PMID: 34674160 Free PMC article. Clinical Trial.
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benzoyl peroxide (BPO) 3.1%/adapalene 0.15% (IDP-126) gel for the treatment of acne. METHODS: In a phase II, double-blind, multicente …
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benz …
Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N, Chalermchai T, Ophaswongse S, Udompataikul M. Jurairattanaporn N, et al. J Med Assoc Thai. 2017 Jan;100(1):78-85. J Med Assoc Thai. 2017. PMID: 29911775 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety between silver nanoparticle gel and 1% clindamycin gel both combine with 2.5% benzoyl peroxide for the treatment of moderate severity of acne vulgaris. ...They were randomized to receive either silver nanoparticle …
OBJECTIVE: To compare the efficacy and safety between silver nanoparticle gel and 1% clindamycin gel both combine with 2.5% benzoy …
Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial.
Santos JB, Almeida OL, Silva LM, Barreto ER. Santos JB, et al. An Bras Dermatol. 2011 Jan-Feb;86(1):50-4. doi: 10.1590/s0365-05962011000100006. An Bras Dermatol. 2011. PMID: 21437522 Clinical Trial. English, Portuguese.
OBJECTIVE: To evaluate the therapeutic efficacy of the topical combination of benzoyl peroxide 5% and clindamycin 1% associated with sun exposure for the treatment of progressive macular hypomelanosis. ...Side effects were more frequent in group A (p = 0.003) …
OBJECTIVE: To evaluate the therapeutic efficacy of the topical combination of benzoyl peroxide 5% and clindamycin 1% as …
Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination.
Bikowski JB. Bikowski JB. J Drugs Dermatol. 2005 Mar-Apr;4(2):164-71. J Drugs Dermatol. 2005. PMID: 15776773 Clinical Trial.
This article will examine various clinical experiences with acne patients successfully treated with topical clindamycin 1% benzoyl peroxide 5% gel (Duac) alone and in combination with other acne treatments. Clindamycin 1% benzoyl peroxide …
This article will examine various clinical experiences with acne patients successfully treated with topical clindamycin 1% benzoyl …
A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ, Holland KT, Bojar R, Levy SF. Cunliffe WJ, et al. Clin Ther. 2002 Jul;24(7):1117-33. doi: 10.1016/s0149-2918(02)80023-6. Clin Ther. 2002. PMID: 12182256 Clinical Trial.
OBJECTIVE: The purpose of this study was to compare the antimicrobial and clinical efficacy and tolerability of clindamycin phosphate 1%/benzoyl peroxide 5% gel formulation with matching clindamycin 1% gel in the treatment of acne vulgaris. ...CONCLUSI …
OBJECTIVE: The purpose of this study was to compare the antimicrobial and clinical efficacy and tolerability of clindamycin phosphate …
Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
Breneman D, Savin R, VandePol C, Vamvakias G, Levy S, Leyden J. Breneman D, et al. Int J Dermatol. 2004 May;43(5):381-7. doi: 10.1111/j.1365-4632.2004.02283.x. Int J Dermatol. 2004. PMID: 15117375 Clinical Trial.
A significant (P = 0.0141) difference in favor of benzoyl peroxide/clindamycin was evident by the third week of treatment. ...Application site reactions were reported in four patients (14.8%) in the benzoyl peroxide/clindamycin group. CON …
A significant (P = 0.0141) difference in favor of benzoyl peroxide/clindamycin was evident by the third week of treatme …
Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
Gans EH, Kligman AM. Gans EH, et al. J Dermatolog Treat. 2002 Sep;13(3):107-10. doi: 10.1080/09546630260199451. J Dermatolog Treat. 2002. PMID: 12227872 Clinical Trial.
BACKGROUND: Benzoyl peroxide and clindamycin are the two most widely prescribed topical antimicrobials in the treatment of acne. AIM: To compare the antimicrobial efficacy, in vivo, of benzoyl peroxide and clindamycin against Propionibact …
BACKGROUND: Benzoyl peroxide and clindamycin are the two most widely prescribed topical antimicrobials in the treatment …
The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
Bucks D, Sarpotdar P, Yu K, Angel A, Del Rosso J. Bucks D, et al. J Drugs Dermatol. 2009 Jul;8(7):634-8. J Drugs Dermatol. 2009. PMID: 19588639 Clinical Trial.
Fixed combination products of clindamycin 1% (as 1.2% clindamycin phosphate) and benzoyl peroxide (BPO) 5% are commonly used in the treatment of acne vulgaris. ...As a result, clindamycin-BPO 2.5% gel appears to provide efficacy comparable to th …
Fixed combination products of clindamycin 1% (as 1.2% clindamycin phosphate) and benzoyl peroxide (BPO) 5% are c …
93 results